Cargando…
Clinical effectiveness of second-line antihyperglycemic drugs on major adverse cardiovascular events: An emulation of a target trial
INTRODUCTION: The cardiovascular benefits of multiple antihyperglycemic drugs as add-on therapies to metformin in the real-practice are unclear. This study aimed to directly compare major adverse cardiovascular events (CVE) associated with these multiple drugs. METHODS: An emulation of a target tria...
Autores principales: | Siriyotha, Sukanya, Lukkunaprasit, Thitiya, Angkananard, Teeranan, Looareesuwan, Panu, McKay, Gareth J., Attia, John, Thakkinstian, Ammarin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922758/ https://www.ncbi.nlm.nih.gov/pubmed/36793285 http://dx.doi.org/10.3389/fendo.2023.1094221 |
Ejemplares similares
-
Effects of second-line antihyperglycemic drugs on the risk of chronic kidney disease: applying a target trial approach to a hospital-based cohort of Thai patients with type 2 diabetes
por: Siriyotha, Sukanya, et al.
Publicado: (2022) -
Causal Associations of Urate With Cardiovascular Risk Factors: Two-Sample Mendelian Randomization
por: Lukkunaprasit, Thitiya, et al.
Publicado: (2021) -
An updated meta-analysis of effects of curcumin on metabolic dysfunction-associated fatty liver disease based on available evidence from Iran and Thailand
por: Lukkunaprasit, Thitiya, et al.
Publicado: (2023) -
Neutrophil Lymphocyte Ratio and Cardiovascular Disease Risk: A Systematic Review and Meta-Analysis
por: Angkananard, Teeranan, et al.
Publicado: (2018) -
The Reversal of Bleeding Caused by New Oral Anticoagulants (NOACs): A Systematic Review and Meta-Analysis
por: Udayachalerm, Sariya, et al.
Publicado: (2018)